APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Contrast Agents for Magnetic Resonance Imaging (MRI)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook and Growth Opportunities 2026

Report ID 173980810422 December 2025198 pages

Choose your research edition.

Industry ResearchContrast Agents for Magnetic Resonance Imaging (MRI) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Contrast Agents for Magnetic Resonance Imaging (MRI) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Contrast Agents for Magnetic Resonance Imaging (MRI) market include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contrast Agents for Magnetic Resonance Imaging (MRI) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contrast Agents for Magnetic Resonance Imaging (MRI) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contrast Agents for Magnetic Resonance Imaging (MRI) market size, projected growth trends, production technologies, key applications, and end-use industries.

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application

Radiology

Interventional Radiology

Interventional Cardiology

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Contrast Agents for Magnetic Resonance Imaging (MRI) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Contrast Agents for Magnetic Resonance Imaging (MRI) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Contrast Agents for Magnetic Resonance Imaging (MRI) significant trends, drivers, influence factors in global and regions.

6. To analyze Contrast Agents for Magnetic Resonance Imaging (MRI) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents for Magnetic Resonance Imaging (MRI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents for Magnetic Resonance Imaging (MRI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contrast Agents for Magnetic Resonance Imaging (MRI) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contrast Agents for Magnetic Resonance Imaging (MRI) industry.

Chapter 3: Detailed analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Contrast Agents for Magnetic Resonance Imaging (MRI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Contrast Agents for Magnetic Resonance Imaging (MRI) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends Table 2. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers Table 3. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges Table 4. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints Table 5. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Company (2021-2026) Table 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Company (2021-2026) Table 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (US$/unit) of Company (2021-2026) Table 10. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Key Company Manufacturing Base & Headquarters Table 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company, Product Type & Application Table 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Microbubble Contrast Media Table 18. Significant Companies of Gadolinium-based Contrast Media Table 19. Significant Companies of Iodinated Contrast Media Table 20. Significant Companies of Barium-based Contrast Media Table 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type (2021-2026) & (k units) Table 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type (2027-2032) & (k units) Table 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Type (2021-2026) Table 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Type (2027-2032) Table 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type (2021-2026) Table 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Radiology Table 32. Significant Companies of Interventional Radiology Table 33. Significant Companies of Interventional Cardiology Table 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application (2021-2026) & (k units) Table 36. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application (2027-2032) & (k units) Table 37. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Application (2021-2026) Table 38. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Application (2027-2032) Table 39. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application (2021-2026) Table 43. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application (2027-2032) Table 44. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2026) & (k units) Table 46. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2021-2026) Table 47. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2027-2032) & (k units) Table 48. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2027-2032) Table 49. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Region (2021-2026) Table 52. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Region (2027-2032) Table 54. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 59. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2026) Table 60. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 61. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2027-2032) Table 62. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Market Share by Country (2021-2026) Table 64. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Market Share by Country (2027-2032) Table 66. Daiichi Sankyo (Japan) Company Information Table 67. Daiichi Sankyo (Japan) Business Overview Table 68. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 70. Daiichi Sankyo (Japan) Recent Development Table 71. Bayer HealthCare (Germany) Company Information Table 72. Bayer HealthCare (Germany) Business Overview Table 73. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 75. Bayer HealthCare (Germany) Recent Development Table 76. Unijules Life Sciences (India) Company Information Table 77. Unijules Life Sciences (India) Business Overview Table 78. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 80. Unijules Life Sciences (India) Recent Development Table 81. Taejoon Pharm (South Korea) Company Information Table 82. Taejoon Pharm (South Korea) Business Overview Table 83. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 85. Taejoon Pharm (South Korea) Recent Development Table 86. Spago Nanomedicine (Sweden) Company Information Table 87. Spago Nanomedicine (Sweden) Business Overview Table 88. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 90. Spago Nanomedicine (Sweden) Recent Development Table 91. Magnus Health (India) Company Information Table 92. Magnus Health (India) Business Overview Table 93. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 95. Magnus Health (India) Recent Development Table 96. Lantheus (US) Company Information Table 97. Lantheus (US) Business Overview Table 98. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 100. Lantheus (US) Recent Development Table 101. Jodas (India) Company Information Table 102. Jodas (India) Business Overview Table 103. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 105. Jodas (India) Recent Development Table 106. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 107. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 108. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 110. J.B. Chemicals and Pharmaceuticals (India) Recent Development Table 111. Guerbet (France) Company Information Table 112. Guerbet (France) Business Overview Table 113. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 115. Guerbet (France) Recent Development Table 116. GE Healthcare (US) Company Information Table 117. GE Healthcare (US) Business Overview Table 118. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 120. GE Healthcare (US) Recent Development Table 121. Bracco Imaging (Italy) Company Information Table 122. Bracco Imaging (Italy) Business Overview Table 123. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 125. Bracco Imaging (Italy) Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List Table 129. Contrast Agents for Magnetic Resonance Imaging (MRI) Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Product Image Figure 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (2021-2032) & (k units) Figure 5. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Microbubble Contrast Media Image Figure 10. Gadolinium-based Contrast Media Image Figure 11. Iodinated Contrast Media Image Figure 12. Barium-based Contrast Media Image Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Type (2021-2032) Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type (2021-2032) Figure 19. Radiology Image Figure 20. Interventional Radiology Image Figure 21. Interventional Cardiology Image Figure 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Application (2021-2032) Figure 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application (2021-2032) Figure 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Radiology
  • Interventional Radiology
  • Interventional Cardiology
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032)
  4. 1.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2021-2032)
  5. 1.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Dynamics
  1. 2.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends
  2. 2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers
  3. 2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges
  4. 2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints
3 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Company
  1. 3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Revenue Ranking in 2025
  2. 3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Company (2021-2026)
  3. 3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Company (2021-2026)
  4. 3.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Company (2021-2026)
  5. 3.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Ranking (2024-2026)
  6. 3.6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Manufacturing Base and Headquarters
  7. 3.7 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Product Type and Application
  8. 3.8 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Contrast Agents for Magnetic Resonance Imaging (MRI) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Type
  1. 4.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Type Introduction
  2. 4.1.1 Microbubble Contrast Media
  3. 4.1.2 Gadolinium-based Contrast Media
  4. 4.1.3 Iodinated Contrast Media
  5. 4.1.4 Barium-based Contrast Media
  6. 4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type
  7. 4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type
  11. 4.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type (2021-2032)
5 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Application
  1. 5.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Application Introduction
  2. 5.1.1 Radiology
  3. 5.1.2 Interventional Radiology
  4. 5.1.3 Interventional Cardiology
  5. 5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application
  6. 5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application
  10. 5.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application (2021-2032)
6 Contrast Agents for Magnetic Resonance Imaging (MRI) Regional Sales and Value Analysis
  1. 6.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2032)
  3. 6.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021-2026
  4. 6.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2027-2032)
  5. 6.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region (2027-2032)
  9. 6.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032)
  12. 6.6.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032)
  15. 6.7.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032)
  21. 6.9.2 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Country, 2025 VS 2032
7 Contrast Agents for Magnetic Resonance Imaging (MRI) Country-level Sales and Value Analysis
  1. 7.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  4. 7.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026)
  5. 7.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032)
  6. 7.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Daiichi Sankyo (Japan)
  2. 8.1.1 Daiichi Sankyo (Japan) Company Information
  3. 8.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 8.1.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  6. 8.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 8.2 Bayer HealthCare (Germany)
  8. 8.2.1 Bayer HealthCare (Germany) Company Information
  9. 8.2.2 Bayer HealthCare (Germany) Business Overview
  10. 8.2.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  12. 8.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 8.3 Unijules Life Sciences (India)
  14. 8.3.1 Unijules Life Sciences (India) Company Information
  15. 8.3.2 Unijules Life Sciences (India) Business Overview
  16. 8.3.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  18. 8.3.5 Unijules Life Sciences (India) Recent Developments
  19. 8.4 Taejoon Pharm (South Korea)
  20. 8.4.1 Taejoon Pharm (South Korea) Company Information
  21. 8.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 8.4.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  24. 8.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 8.5 Spago Nanomedicine (Sweden)
  26. 8.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 8.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 8.5.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  30. 8.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 8.6 Magnus Health (India)
  32. 8.6.1 Magnus Health (India) Company Information
  33. 8.6.2 Magnus Health (India) Business Overview
  34. 8.6.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  36. 8.6.5 Magnus Health (India) Recent Developments
  37. 8.7 Lantheus (US)
  38. 8.7.1 Lantheus (US) Company Information
  39. 8.7.2 Lantheus (US) Business Overview
  40. 8.7.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  42. 8.7.5 Lantheus (US) Recent Developments
  43. 8.8 Jodas (India)
  44. 8.8.1 Jodas (India) Company Information
  45. 8.8.2 Jodas (India) Business Overview
  46. 8.8.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  48. 8.8.5 Jodas (India) Recent Developments
  49. 8.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 8.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 8.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 8.9.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  54. 8.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 8.10 Guerbet (France)
  56. 8.10.1 Guerbet (France) Company Information
  57. 8.10.2 Guerbet (France) Business Overview
  58. 8.10.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  60. 8.10.5 Guerbet (France) Recent Developments
  61. 8.11 GE Healthcare (US)
  62. 8.11.1 GE Healthcare (US) Company Information
  63. 8.11.2 GE Healthcare (US) Business Overview
  64. 8.11.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  66. 8.11.5 GE Healthcare (US) Recent Developments
  67. 8.12 Bracco Imaging (Italy)
  68. 8.12.1 Bracco Imaging (Italy) Company Information
  69. 8.12.2 Bracco Imaging (Italy) Business Overview
  70. 8.12.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  72. 8.12.5 Bracco Imaging (Italy) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Analysis
  2. 9.1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Mode & Process
  6. 9.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
  9. 9.2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst